JSM2023
Back to all people

Zheng Li

Novartis Pharmaceuticals
1 appearance in the program

Sessions & presentations

Time to Event and Composite Endpoint Applications in Clinical Trials
Presentation: Estimating the PFS treatment effect in a dose ranging study accounting for dose reduction
Contributed Papers · Wed, Aug 9 , 10:30 AM
Speaker
↑